Follow the Journey Medical Corp share price and the full insider trade history of the company, a listed issuer based in United States. Shares are listed on US US, under the authority of SEC (Form 4). Operating in the Health Care sector, Journey Medical Corp has logged 55 insider filings. Market capitalisation: €195.2m. The latest transaction was filed on 26 June 2026 (Attribution). Among the most active insiders: Maraoui Claude. Every trade is free.
55
Insider Decl.
0
Thresholds
€707,018
9 ops.
Buy Volume
€740,002
18 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate Journey Medical Corp Strong Buy (bullish), based on 4 analysts. Average price target: US$13.50.
43Σ signal
Buys €707,018€740,002 Sells
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental score
Ranked 22,014 of 25,791 companies
26.4
score / 100
Value
19
Quality
33
FCF yld-6.8%
Earn yld-6.2%
EV/EBITDA·
ROE-37%
Gross mgn66%
Net mgn-18%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
10,000 shares@ US$3.4795.0% of flowCommon Stock, $0.0001 par valueSEC:0001104659-24-038437:0
Ideal exit: 17 Dec 2024 (T+270)
25 of 55 declarations
About Journey Medical Corp
Journey Medical Corp is a company focused on the development and commercialization of dermatological treatments. It is listed on NASDAQ under the ticker XNAS.